TGFB1 and liver disorder: Additionally, the intrahepatic expression levels of potentially anti-inflammatory/hepatoprotective cytokines such as IL-10, IL-22 or TGF-β [28]–[30] were not reduced in CD8 T cell-injected Clo-L-treated mice when compared to proper controls (Figure 2, D, E and F), indicating that the increased liver disease observed in the former animals was not associated to decreased production of cytoprotective factors.